Suzanne M. Gilboa
Centers for Disease Control and Prevention(US)National Center on Birth Defects and Developmental Disabilities(US)Response Biomedical (Canada)(CA)Computer Emergency Response Team(FR)Response Technologies (United States)(US)
Publications by Year
Research Areas
Global Maternal and Child Health, COVID-19 Impact on Reproduction, Mosquito-borne diseases and control, Maternal Mental Health During Pregnancy and Postpartum, Pregnancy and Medication Impact
Most-Cited Works
- → Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020(2020)1,252 cited
- → Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–June 7, 2020(2020)1,091 cited
- → Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008(2011)809 cited
- → Congenital Heart Defects in the United States(2016)688 cited
- → Diabetes mellitus and birth defects(2008)672 cited
- → Mortality Resulting From Congenital Heart Disease Among Children and Adults in the United States, 1999 to 2006(2010)604 cited